|
Jun 21
|
5 Things to Know Before the Stock Market Opens
|
|
Jun 21
|
Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?
|
|
Jun 21
|
CarMax, Gilead and Sarepta rise premarket; Nvidia falls
|
|
Jun 20
|
Housing trends, HPE CEO on Nvidia partnership: Market Domination
|
|
Jun 20
|
S&P 500 Gains and Losses Today: Index Dips After Briefly Crossing 5,500
|
|
Jun 20
|
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
|
|
Jun 20
|
Why Wall Street Is Chasing Ozempic Wannabes
|
|
Jun 20
|
US Equities Markets Close Mixed Thursday as Markets Parse Latest Economic Data
|
|
Jun 20
|
Gilead Sciences stock jumps on HIV treatment trial success
|
|
Jun 20
|
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
|
|
Jun 20
|
Sector Update: Health Care Stocks Higher Late Afternoon
|
|
Jun 20
|
Gilead Stock Surges on Strong Results in HIV Drug Study
|
|
Jun 17
|
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
|
|
Jun 14
|
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
|
|
Jun 14
|
Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.
|
|
Jun 14
|
New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment
|
|
Jun 13
|
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
|
|
Jun 12
|
How Luciana Preger Is Helping Advance Gilead’s Work in Oncology
|
|
Jun 8
|
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
|
|
Jun 7
|
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
|